APA (7th ed.) Citation

Radtke, J. P., Nyarangi-Dix, J., Schütz, V., Dieffenbacher, S., Görtz, M., Stenzinger, A., . . . Hohenfellner, M. (2019). Prediction of significant prostate cancer in biopsy-naïve men: Validation of a novel risk model combining MRI and clinical parameters and comparison to an ERSPC risk calculator and PI-RADS. PLOS ONE, 14(8), . https://doi.org/10.1371/journal.pone.0221350

Chicago Style (17th ed.) Citation

Radtke, Jan Philipp, Joanne Nyarangi-Dix, Viktoria Schütz, Svenja Dieffenbacher, Magdalena Görtz, Albrecht Stenzinger, David Bonekamp, Heinz-Peter Schlemmer, and Markus Hohenfellner. "Prediction of Significant Prostate Cancer in Biopsy-naïve Men: Validation of a Novel Risk Model Combining MRI and Clinical Parameters and Comparison to an ERSPC Risk Calculator and PI-RADS." PLOS ONE 14, no. 8 (2019). https://doi.org/10.1371/journal.pone.0221350.

MLA (9th ed.) Citation

Radtke, Jan Philipp, et al. "Prediction of Significant Prostate Cancer in Biopsy-naïve Men: Validation of a Novel Risk Model Combining MRI and Clinical Parameters and Comparison to an ERSPC Risk Calculator and PI-RADS." PLOS ONE, vol. 14, no. 8, 2019, https://doi.org/10.1371/journal.pone.0221350.